3 of Frank Sands' Top 5 Transactions in 2nd Quarter Were Reductions

Guru trims stakes in Under Armour, LinkedIn, Regeneron

Author's Avatar
Aug 14, 2016
Article's Main Image

Of his top five second-quarter transactions, Frank Sands (Trades, Portfolio) made reductions in three of his stakes – Under Armour Inc. (UA, Financial), LinkedIn Corp. (LNKD, Financial) and Regeneron Pharmaceuticals Inc. (REGN, Financial). Rounding out Sands’ top five were the purchase of a stake in Under Armour’s UA.C stock and an increase in his position in The Priceline Group Inc. (PCLN, Financial).

Sands trimmed more than half of his position in Under Armour, a Baltimore-based athletic apparel and accessories company, for an average price of $39.98 per share. Sands sold 9,450,920 shares in a transaction that had a -1.18% impact on his portfolio.

Sands’ remaining stake of 8,420,094 shares is 1.93% of Under Armour’s outstanding shares and 1.04% of Sands’ total assets. He is now the company’s second-leading shareholder among the gurus behind Ron Baron (Trades, Portfolio), whose 9,983,516-share stake is 2.28% of Under Armour’s outstanding shares is 2.28% of the company’s outstanding shares and 2.24% of Baron’s total assets.

Under Armour has a price-earnings (P/E) ratio of 108.1, a forward P/E of 68.5, a price-book (P/B) ratio of 10.1 and a price-sales (P/S) ratio of 4.1. GuruFocus gives Under Armour a Financial Strength rating of 6/10 and a Profitability and Growth rating of 7/10 with return on equity (ROE) of 10.61% that is higher than 65% of the companies in the Global Apparel Manufacturing industry and return on assets (ROA) of 7.56% that is higher than 69% of the companies in that industry.

02May2017154412.png

Under Armour sold for $41.09 per share at market close Friday. The DCF Calculator gives Under Armour a fair value of $11.1.

Sands sold nearly 43% of his stake in LinkedIn, a California-based social networking service, for an average price of $191.61 per share. Sands sold 3,141,753 shares in a deal that had a -1.06% impact on his portfolio.

The guru’s remaining stake of 4,202,770 shares is 3.12% of LinkedIn’s outstanding shares and 2.46% of Sands’ total assets. Sands is LinkedIn’s leading shareholder among the gurus.

LinkedIn has a forward P/E of 55.6, a P/B of 5.5 and a P/S of 7.4. GuruFocus gives LinkedIn a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10 with ROE of -4.95% that is lower than 68% of the companies in the Global Internet Content & Information industry and ROA of -3.17% that is lower than 64% of the companies in that industry.

02May2017154412.png

LinkedIn sold for $191.61 per share Friday. The DCF Calculator gives LinkedIn a fair value of $-17.76.

Sands reduced his stake in Regeneron, a New York-based pharmaceutical company, by more than 21%. Sands sold 728,180 shares for an average price of $384.74 per share. The transaction had a -0.78% impact on Sands’ portfolio.

Sands retains a stake of 2,659,741 shares, which is 2.53% of Regeneron’s outstanding shares and 2.87% of Sands’ total assets. Vanguard Health Care Fund (Trades, Portfolio) is now Regeneron’s leading shareholder among the gurus with a stake of 3,279,190 shares. The stake is 3.11% of Regeneron’s outstanding shares and 2.43% of Vanguard’s total assets.

Regeneron has a P/E of 66.9, a forward P/E of 38.2, a P/B of 10.9 and a P/S of 10.5. GuruFocus gives Regeneron a Financial Strength rating of 8/10 and a Profitability and Growth rating of 6/10 with ROE of 20.06% and ROA of 13.26% that are higher than 93% of the companies in the Global Biotechnology industry.

02May2017154413.png

Regeneron sold for $421.54 per share Friday. The DCF Calculator gives Regeneron a fair value of $67.42.

As Sands was reducing his stake in Under Armour’s UA shares, he was buying an 8,480,965-share stake in the company’s UA.C stock for an average price of $37.47. The acquisition had a 0.95% impact on Sands’ portfolio.

The stake is 1.94% of the company’s outstanding UA.C shares and 0.95% of Sands’ total assets. Sands is UA.C’s leading shareholder among the gurus.

02May2017154413.png

The UA.C shares sold for $37.1 per share Friday. The DCF Calculator gives the UA.C shares a fair value of $11.1.

Sands raised his position in Priceline, a Connecticut-based travel and technology company, by nearly 20%. The guru purchased 196,758 shares for an average price of $1,297.66 per share. The transaction had a 0.76% impact on Sands’ portfolio.

Sands’ stake, now 1,181,218 shares, is 2.39% of Priceline’s outstanding shares and 4.56% of Sands’ total assets. Sands is Priceline’s leading shareholder among the gurus.

Priceline has a P/E of 26.8, a forward P/E of 21.1, a P/B of 7.5 and a P/S of 7.3. GuruFocus gives Priceline a Financial Strength rating of 6/10 and a Profitability and Growth rating of 9/10 with ROE of 30.04% that is higher than 94% of companies in the Global Leisure industry and ROA of 14.91% that is higher than 93% of the companies in that industry.

Priceline sold for $1,407.98 per share Friday. The DCF Calculator gives Priceline a fair value of $1,495.44 with a 6% margin of safety.

Start a free seven-day trial of Premium Membership to GuruFocus.